Abiopharma

🔍 Czerney Kevin (Executive)

Company: DENTSPLY SIRONA Inc. (XRAY)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Acquired 263 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 28,040.79 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 4 shares of Phantom Stock (Dentsply Supplemental Savings Plan) DSSP (Derivative)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 341.20 | transaction_form_type: 4 | Footnotes: F4, F5, F4, F4
• Acquired 45 shares of Phantom Stock (Supplemental Executive Retirement Plan) SERP (Derivative)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,493.43 | transaction_form_type: 4 | Footnotes: F4, F4, F4

Footnotes:

• F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
• F2: Includes 514 shares acquired between July 1st - December 31, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.
• F3: Includes 112.122 shares acquired through dividend reinvestment on 1/9/2026.
• F4: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
• F5: Comprised of phantom stock acquired as a result of accrued dividends.